Making the Decision to Stop — A Framework for Families

Weighing the decision means bringing three things to your oncologist together: the real cost and burden of continuing, what your latest scans and blood tests actually show, and what matters most to you right now. This is a shared, clinician-led conversation — not a number you calculate alone or a moment you announce after deciding.

The same framework applies whether the trigger is the cost of ongoing cycles, tiredness with the whole process, or a scan that shows the disease isn't responding the way it was. None of these reasons is more "valid" than another — each is a real input your care team should take seriously.

This page cannot tell you whether to stop or continue — no honest page can, because that depends on your specific cancer, your specific scans, and your specific priorities. What it can give you is a clear way to structure that conversation with your treating oncologist.

Three triggers bring most families to this conversation, often more than one at once. Cost is the reason named most often — the per-cycle expense, tests and travel add up over months, and weighing that against the treatment's expected benefit is due diligence, not a lack of hope. Treatment fatigue is the second — the physical and emotional toll of repeat hospital visits and cumulative side effects wearing a patient and their caregivers down. The third is the disease itself — a scan or blood report suggesting the response has plateaued or the cancer is progressing despite treatment.

If part of what's holding you back from raising this is the fear that it means giving up, you are not alone in that fear — and it deserves a direct answer, which this page comes back to below.

Continuing treatment as planned remains a valid answer too — for many families, it is the right one. Nothing on this page is a signal to stop.

Your treating oncologist leads this conversation clinically, but the decision is rarely made by one person alone. Most families include the patient wherever possible, one or two close family members who share caregiving, and sometimes a palliative-care specialist — brought in for comfort and symptom guidance, not because the goal is changing to end-of-life care.

If family members disagree — a patient wanting to stop while an adult child wants to keep trying, or the reverse — that is common, not a problem you need to resolve before you show up. Oncology teams are used to helping families work through differing views as part of the conversation, not a precondition for having it.

Four moments typically bring this up: reaching the end of a planned course length, a scheduled response-assessment scan that shows the benefit has plateaued, side effects severe enough to need repeated dose delays, or a billing-cycle review that makes the cost genuinely unsustainable. Any one of these is a legitimate reason to raise the question with your oncologist.

It does not have to wait for a scheduled appointment. If cost, fatigue or a result you don't understand is weighing on you between visits, that is reason enough to call and ask for the conversation sooner.

No. Many patients who pause or stop disease-directed treatment continue other care, and some go on to stay well for extended periods without further treatment — sometimes called treatment-free remission — while being monitored closely by their oncology team. Choosing comfort and quality of life is a decision, not a defeat.

For patients with advanced or palliative-stage disease especially, prioritising time and comfort over an additional treatment cycle with uncertain benefit is itself a considered, respected choice, made with the same care as choosing to continue. No page can promise you what will happen after stopping — only your oncology team, looking at your own case, can speak to that honestly.

• If part of your hope is that life after stopping can still go well, Treatment-Free Remission: Staying Well After Stopping explains what that actually looks like, honestly.
• If keeping the door open matters to you, Restarting Immunotherapy After a Break covers what determines whether that's still possible.
• If what's actually being discussed is a pause rather than stopping for good, Taking a Planned Break From Immunotherapy explains how that's different and how it's managed.
• For the full picture of immunotherapy at CION — how it's delivered, monitored and managed — see our immunotherapy hub.

This page is general patient-education information, not a substitute for the written guidance your own oncology team gives you based on your specific diagnosis and treatment plan. It does not state or imply any recurrence risk tied to continuing or stopping treatment.

Whatever You Decide, Decide With Full Information

A medical oncologist can walk through the realistic benefit, the cost, and what continues either way for your specific case — so the decision, in either direction, is genuinely informed.

This page is general patient-education information, not a substitute for the written guidance your own oncology team gives you based on your specific diagnosis and treatment plan.